芍药苷

Paeoniflorin is the main bioactive component isolated from the root of Paeonia lactiflora Pall.
芍药苷是从小白花芍药根部分离出的主要生物活性成分。
In traditional Chinese medicine, paeoniflorin exhibits significant anti-inflammatory and analgesic effects.
在传统中药中，芍药苷显示出显著的抗炎和镇痛效果。
Researchers have found that paeoniflorin can effectively regulate the immune system response.
研究者发现芍药苷能有效调节免疫系统反应。
The pharmacokinetics of paeoniflorin in rats after oral administration was studied to understand its absorption and metabolism.
通过研究口服后大鼠体内的芍药苷药代动力学，以了解其吸收和代谢情况。
Paeoniflorin has been reported to possess neuroprotective properties against ischemic brain injury.
已有报道称芍药苷对缺血性脑损伤具有神经保护作用。
Clinical trials are underway to evaluate the efficacy of paeoniflorin in treating cardiovascular diseases.
正在进行临床试验以评估芍药苷治疗心血管疾病的疗效。
The structure-activity relationship study of paeoniflorin suggests its potential for further drug development.
芍药苷的结构-活性关系研究表明它有进一步药物开发的潜力。
Paeoniflorin extracted from peony root has shown promise as an antioxidant agent.
从牡丹根提取的芍药苷作为抗氧化剂表现出良好的前景。
Its antitumor activities make paeoniflorin a promising candidate for cancer therapy.
其抗肿瘤活性使得芍药苷成为癌症治疗的一种有前途的候选物质。
The combination of paeoniflorin with other herbal ingredients may enhance its therapeutic effect on osteoarthritis.
芍药苷与其他草药成分联合使用可能增强其对骨关节炎的治疗效果。